Global Celiac Disease Drugs Market Research Report 2023

Report ID: 1982507 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Celiac Disease Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 First Line of Treatment
        1.2.3 Second Line of Treatment
    1.3 Market by Application
        1.3.1 Global Celiac Disease Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Celiac Disease Drugs Market Perspective (2017-2028)
    2.2 Celiac Disease Drugs Growth Trends by Region
        2.2.1 Celiac Disease Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Celiac Disease Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Celiac Disease Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Celiac Disease Drugs Market Dynamics
        2.3.1 Celiac Disease Drugs Industry Trends
        2.3.2 Celiac Disease Drugs Market Drivers
        2.3.3 Celiac Disease Drugs Market Challenges
        2.3.4 Celiac Disease Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Celiac Disease Drugs Players by Revenue
        3.1.1 Global Top Celiac Disease Drugs Players by Revenue (2017-2022)
        3.1.2 Global Celiac Disease Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Celiac Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Celiac Disease Drugs Revenue
    3.4 Global Celiac Disease Drugs Market Concentration Ratio
        3.4.1 Global Celiac Disease Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Drugs Revenue in 2021
    3.5 Celiac Disease Drugs Key Players Head office and Area Served
    3.6 Key Players Celiac Disease Drugs Product Solution and Service
    3.7 Date of Enter into Celiac Disease Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Celiac Disease Drugs Breakdown Data by Type
    4.1 Global Celiac Disease Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Celiac Disease Drugs Forecasted Market Size by Type (2023-2028)
5 Celiac Disease Drugs Breakdown Data by Application
    5.1 Global Celiac Disease Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Celiac Disease Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Celiac Disease Drugs Market Size (2017-2028)
    6.2 North America Celiac Disease Drugs Market Size by Country (2017-2022)
    6.3 North America Celiac Disease Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Celiac Disease Drugs Market Size (2017-2028)
    7.2 Europe Celiac Disease Drugs Market Size by Country (2017-2022)
    7.3 Europe Celiac Disease Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Celiac Disease Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Celiac Disease Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Celiac Disease Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Celiac Disease Drugs Market Size (2017-2028)
    9.2 Latin America Celiac Disease Drugs Market Size by Country (2017-2022)
    9.3 Latin America Celiac Disease Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Celiac Disease Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Celiac Disease Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Celiac Disease Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Detail
        11.1.2 Roche Business Overview
        11.1.3 Roche Celiac Disease Drugs Introduction
        11.1.4 Roche Revenue in Celiac Disease Drugs Business (2017-2022)
        11.1.5 Roche Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Celiac Disease Drugs Introduction
        11.2.4 Merck Revenue in Celiac Disease Drugs Business (2017-2022)
        11.2.5 Merck Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Detail
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Celiac Disease Drugs Introduction
        11.3.4 Johnson & Johnson Revenue in Celiac Disease Drugs Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Development
    11.4 BiolineRx
        11.4.1 BiolineRx Company Detail
        11.4.2 BiolineRx Business Overview
        11.4.3 BiolineRx Celiac Disease Drugs Introduction
        11.4.4 BiolineRx Revenue in Celiac Disease Drugs Business (2017-2022)
        11.4.5 BiolineRx Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Detail
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Celiac Disease Drugs Introduction
        11.5.4 Pfizer Revenue in Celiac Disease Drugs Business (2017-2022)
        11.5.5 Pfizer Recent Development
    11.6 Innovate Biopharmaceuticals
        11.6.1 Innovate Biopharmaceuticals Company Detail
        11.6.2 Innovate Biopharmaceuticals Business Overview
        11.6.3 Innovate Biopharmaceuticals Celiac Disease Drugs Introduction
        11.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Drugs Business (2017-2022)
        11.6.5 Innovate Biopharmaceuticals Recent Development
    11.7 ImmusanT
        11.7.1 ImmusanT Company Detail
        11.7.2 ImmusanT Business Overview
        11.7.3 ImmusanT Celiac Disease Drugs Introduction
        11.7.4 ImmusanT Revenue in Celiac Disease Drugs Business (2017-2022)
        11.7.5 ImmusanT Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Celiac Disease Drugs Introduction
        11.8.4 Novartis Revenue in Celiac Disease Drugs Business (2017-2022)
        11.8.5 Novartis Recent Development
    11.9 Bristol-Myers Squibb
        11.9.1 Bristol-Myers Squibb Company Detail
        11.9.2 Bristol-Myers Squibb Business Overview
        11.9.3 Bristol-Myers Squibb Celiac Disease Drugs Introduction
        11.9.4 Bristol-Myers Squibb Revenue in Celiac Disease Drugs Business (2017-2022)
        11.9.5 Bristol-Myers Squibb Recent Development
    11.10 Immunomedics
        11.10.1 Immunomedics Company Detail
        11.10.2 Immunomedics Business Overview
        11.10.3 Immunomedics Celiac Disease Drugs Introduction
        11.10.4 Immunomedics Revenue in Celiac Disease Drugs Business (2017-2022)
        11.10.5 Immunomedics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Celiac Disease Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of First Line of Treatment
    Table 3. Key Players of Second Line of Treatment
    Table 4. Global Celiac Disease Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Celiac Disease Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Celiac Disease Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Celiac Disease Drugs Market Share by Region (2017-2022)
    Table 8. Global Celiac Disease Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Celiac Disease Drugs Market Share by Region (2023-2028)
    Table 10. Celiac Disease Drugs Market Trends
    Table 11. Celiac Disease Drugs Market Drivers
    Table 12. Celiac Disease Drugs Market Challenges
    Table 13. Celiac Disease Drugs Market Restraints
    Table 14. Global Celiac Disease Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Celiac Disease Drugs Market Share by Players (2017-2022)
    Table 16. Global Top Celiac Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drugs as of 2021)
    Table 17. Ranking of Global Top Celiac Disease Drugs Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Celiac Disease Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Celiac Disease Drugs Product Solution and Service
    Table 21. Date of Enter into Celiac Disease Drugs Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Celiac Disease Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Celiac Disease Drugs Revenue Market Share by Type (2017-2022)
    Table 25. Global Celiac Disease Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Celiac Disease Drugs Revenue Market Share by Type (2023-2028)
    Table 27. Global Celiac Disease Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Celiac Disease Drugs Revenue Market Share by Application (2017-2022)
    Table 29. Global Celiac Disease Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Celiac Disease Drugs Revenue Market Share by Application (2023-2028)
    Table 31. North America Celiac Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Celiac Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Celiac Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Celiac Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Celiac Disease Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Celiac Disease Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Celiac Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Celiac Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Celiac Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Celiac Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Roche Company Detail
    Table 42. Roche Business Overview
    Table 43. Roche Celiac Disease Drugs Product
    Table 44. Roche Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
    Table 45. Roche Recent Development
    Table 46. Merck Company Detail
    Table 47. Merck Business Overview
    Table 48. Merck Celiac Disease Drugs Product
    Table 49. Merck Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
    Table 50. Merck Recent Development
    Table 51. Johnson & Johnson Company Detail
    Table 52. Johnson & Johnson Business Overview
    Table 53. Johnson & Johnson Celiac Disease Drugs Product
    Table 54. Johnson & Johnson Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
    Table 55. Johnson & Johnson Recent Development
    Table 56. BiolineRx Company Detail
    Table 57. BiolineRx Business Overview
    Table 58. BiolineRx Celiac Disease Drugs Product
    Table 59. BiolineRx Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
    Table 60. BiolineRx Recent Development
    Table 61. Pfizer Company Detail
    Table 62. Pfizer Business Overview
    Table 63. Pfizer Celiac Disease Drugs Product
    Table 64. Pfizer Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
    Table 65. Pfizer Recent Development
    Table 66. Innovate Biopharmaceuticals Company Detail
    Table 67. Innovate Biopharmaceuticals Business Overview
    Table 68. Innovate Biopharmaceuticals Celiac Disease Drugs Product
    Table 69. Innovate Biopharmaceuticals Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
    Table 70. Innovate Biopharmaceuticals Recent Development
    Table 71. ImmusanT Company Detail
    Table 72. ImmusanT Business Overview
    Table 73. ImmusanT Celiac Disease Drugs Product
    Table 74. ImmusanT Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
    Table 75. ImmusanT Recent Development
    Table 76. Novartis Company Detail
    Table 77. Novartis Business Overview
    Table 78. Novartis Celiac Disease Drugs Product
    Table 79. Novartis Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
    Table 80. Novartis Recent Development
    Table 81. Bristol-Myers Squibb Company Detail
    Table 82. Bristol-Myers Squibb Business Overview
    Table 83. Bristol-Myers Squibb Celiac Disease Drugs Product
    Table 84. Bristol-Myers Squibb Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
    Table 85. Bristol-Myers Squibb Recent Development
    Table 86. Immunomedics Company Detail
    Table 87. Immunomedics Business Overview
    Table 88. Immunomedics Celiac Disease Drugs Product
    Table 89. Immunomedics Revenue in Celiac Disease Drugs Business (2017-2022) & (US$ Million)
    Table 90. Immunomedics Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Celiac Disease Drugs Market Share by Type: 2021 VS 2028
    Figure 2. First Line of Treatment Features
    Figure 3. Second Line of Treatment Features
    Figure 4. Global Celiac Disease Drugs Market Share by Application in 2021 & 2028
    Figure 5. Hospital Pharmacy Case Studies
    Figure 6. Retail Pharmacy Case Studies
    Figure 7. Online Pharmacy Case Studies
    Figure 8. Others Case Studies
    Figure 9. Celiac Disease Drugs Report Years Considered
    Figure 10. Global Celiac Disease Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Celiac Disease Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Celiac Disease Drugs Market Share by Region: 2021 VS 2028
    Figure 13. Global Celiac Disease Drugs Market Share by Players in 2021
    Figure 14. Global Top Celiac Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drugs as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Celiac Disease Drugs Revenue in 2021
    Figure 16. North America Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Celiac Disease Drugs Market Share by Country (2017-2028)
    Figure 18. United States Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Celiac Disease Drugs Market Share by Country (2017-2028)
    Figure 22. Germany Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Celiac Disease Drugs Market Share by Region (2017-2028)
    Figure 30. China Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Celiac Disease Drugs Market Share by Country (2017-2028)
    Figure 38. Mexico Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Celiac Disease Drugs Market Share by Country (2017-2028)
    Figure 42. Turkey Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Celiac Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Roche Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
    Figure 45. Merck Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
    Figure 46. Johnson & Johnson Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
    Figure 47. BiolineRx Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
    Figure 48. Pfizer Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
    Figure 49. Innovate Biopharmaceuticals Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
    Figure 50. ImmusanT Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
    Figure 51. Novartis Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
    Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
    Figure 53. Immunomedics Revenue Growth Rate in Celiac Disease Drugs Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Frequently Asked Questions
Celiac Disease Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Celiac Disease Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Celiac Disease Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cell Separation

Cell Separation market is segmented by players, region (country), by Type and by Application. Pla ... Read More

Cell Sorter

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Cell Surface Marker

Cell Surface Marker market is segmented by players, region (country), by Type and by Application. ... Read More